189 related articles for article (PubMed ID: 1721317)
1. Combined immunosuppressive effect of FK 506 and other immunosuppressive agents on PHA- and CD3-stimulated human lymphocyte proliferation in vitro.
Jiang H; Suguo H; Takahara S; Takano Y; Li D; Kameoka H; Moutabarrik A; Kokado Y; Ishibashi M; Okuyama A
Transplant Proc; 1991 Dec; 23(6):2933-6. PubMed ID: 1721317
[No Abstract] [Full Text] [Related]
2. FK 506 and deoxyspergualin: additive immunosuppressive effect on rat cardiac allograft rejection in vivo and mitogen-stimulated human lymphocyte responses in vitro.
Jiang H; Takahara S; Li D; Namiki M; Ishibashi M; Okuyama A; Sonoda T
Transplant Proc; 1994 Aug; 26(4):2313-6. PubMed ID: 7520631
[No Abstract] [Full Text] [Related]
3. Comparative in vitro studies on the immunosuppressive activities of mycophenolic acid, bredinin, FK 506, cyclosporine, and rapamycin.
Zeevi A; Woan M; Yao GZ; Venkataramanan R; Todo S; Starzl TE; Duquesnoy RJ
Transplant Proc; 1991 Dec; 23(6):2928-30. PubMed ID: 1721315
[No Abstract] [Full Text] [Related]
4. Synergistic effect of the rapamycin-cyclosporine combination: median effect analysis of in vitro immune performances by human T lymphocytes in PHA, CD3, and MLR proliferative and cytotoxicity assays.
Kahan BD; Gibbons S; Tejpal N; Chou TC; Stepkowski S
Transplant Proc; 1991 Feb; 23(1 Pt 2):1090-1. PubMed ID: 1824888
[No Abstract] [Full Text] [Related]
5. Comparison of the in vitro and biophysical effects of cyclosporine A, FK-506, and mycophenolic acid on human peripheral blood lymphocytes.
Weaver JL; Pine PS; Aszalos A
Immunopharmacol Immunotoxicol; 1991; 13(4):563-76. PubMed ID: 1723084
[TBL] [Abstract][Full Text] [Related]
6. In vitro immunosuppressive effect of deoxymethylspergualin.
Jiang H; Takahara S; Takano Y; Machida M; Iwasaki A; Kokado Y; Kameoka H; Moutabarrik A; Ishibashi M; Sonoda T
Transplant Proc; 1990 Aug; 22(4):1633-7. PubMed ID: 2143857
[No Abstract] [Full Text] [Related]
7. Immunosuppressive activity of cyclosporine metabolites in vitro.
Schlitt HJ; Christians U; Wonigeit K; Sewing KF; Pichlmayr R
Transplant Proc; 1987 Oct; 19(5):4248-51. PubMed ID: 2960052
[No Abstract] [Full Text] [Related]
8. Effect of immunosuppressive agents FK 506 and cyclosporin and steroids on the expression of IL-6 and its receptor by stimulated lymphocytes and monocytes.
Moutabarrik A; Nakanishi I; Takahara S; Hachim K; Bengahnem MG; Ramadani B; Ishibashi M; Zaid D
Transpl Int; 1994; 7 Suppl 1():S552-5. PubMed ID: 11271305
[TBL] [Abstract][Full Text] [Related]
9. Effects of FK 506, mycophenolic acid, and bredinin on OKT-3-, PMA-, and alloantigen-induced activation molecule expression on cultured CD4+ and CD8+ human lymphocytes.
Woo J; Zeevi A; Yao GZ; Strednak J; Todo S; Thomson AW
Transplant Proc; 1991 Dec; 23(6):2939-40. PubMed ID: 1721319
[No Abstract] [Full Text] [Related]
10. Comparative in vitro studies on the immunosuppressive effects of purine and pyrimidine synthesis inhibitors.
Zeevi A; Yao GZ; Venkataramanan R; Duquesnoy RJ; Todo S; Fung JJ; Starzl TE
Transplant Proc; 1993 Feb; 25(1 Pt 1):781-3. PubMed ID: 7679843
[No Abstract] [Full Text] [Related]
11. Assessment of immunosuppression by lymphocyte functions in human blood.
Barten MJ; Rahmel A; Chang H; Tarnok A; Gehlhaar P; Dhein S; Gummert JF
Transplant Proc; 2002 Nov; 34(7):2876-7. PubMed ID: 12431640
[No Abstract] [Full Text] [Related]
12. T lymphocyte activation through the C28 pathway is insensitive to inhibition by the immunosuppressive drug FK-506.
Kay JE; Benzie CR
Immunol Lett; 1989 Dec; 23(2):155-9. PubMed ID: 2483716
[TBL] [Abstract][Full Text] [Related]
13. Effects of cyclosporin A, FK 506, and mycalamide A on the activation of murine CD4+ T cells by the murine B7 antigen.
Galvin F; Freeman GJ; Razi-Wolf Z; Benacerraf B; Nadler L; Reiser H
Eur J Immunol; 1993 Jan; 23(1):283-6. PubMed ID: 7678228
[TBL] [Abstract][Full Text] [Related]
14. A comparison of the sensitivity of pig and human peripheral blood mononuclear cells to the antiproliferative effects of traditional and newer immunosuppressive agents.
Wright DC; Deol HS; Tuch BE
Transpl Immunol; 1999 Sep; 7(3):141-7. PubMed ID: 10608297
[TBL] [Abstract][Full Text] [Related]
15. [The effect of mycophenolic acid on activation antigen expression and in vitro T lymphocytes proliferation in peripheral blood].
Zheng W; Huang H; Xu C
Zhonghua Nei Ke Za Zhi; 2002 May; 41(5):329-32. PubMed ID: 12133428
[TBL] [Abstract][Full Text] [Related]
16. The interaction of IL-2 and IL-4 with the effects of deoxyspergualin.
Kerr PG; Atkins RC
Transplant Proc; 1990 Oct; 22(5):2121-2. PubMed ID: 2219316
[No Abstract] [Full Text] [Related]
17. The in vitro immunosuppressive effect of deoxymethylspergualin in man as compared with FK506 and cyclosporine.
Takahara S; Jiang H; Takano Y; Kokado Y; Ishibashi M; Okuyama A; Sonoda T
Transplantation; 1992 Apr; 53(4):914-8. PubMed ID: 1373537
[TBL] [Abstract][Full Text] [Related]
18. Potential role of 1,25(OH)2 vitamin D3 as a dose-reducing agent for cyclosporine and FK 506.
Mathieu C; Bouillon R; Rutgeerts O; Vandeputte M; Waer M
Transplant Proc; 1994 Dec; 26(6):3130. PubMed ID: 7527950
[No Abstract] [Full Text] [Related]
19. In vitro immunosuppressive effect: a comparative study between deoxymethylspergualin and cyclosporin A, on human lymphocyte responses.
Jiang H; Takahara S; Kokado Y; Ishibashi M; Sonoda T
J Clin Lab Immunol; 1990 Oct; 33(2):75-81. PubMed ID: 1967069
[TBL] [Abstract][Full Text] [Related]
20. Regulatory properties of polysaccharopeptide derived from Coriolus versicolor and its combined effect with ciclosporin on the homeostasis of human lymphocytes.
Lee CL; Jiang P; Sit WH; Yang X; Wan JM
J Pharm Pharmacol; 2010 Aug; 62(8):1028-36. PubMed ID: 20663037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
